المؤلفون: Pantano F., Russano M., Berruti A., Mansueto G., Migliorino M. R., Adamo V., Aprile G., Gelibter A., Ficorella C., Falcone A., Russo A., Aieta M., Maio M., Martelli O., Barni S., Napolitano A., Roca E., Quadrini S., Iacono D., Calvetti L., Occhipinti M. A., Cortellini A., Vasile E., Passiglia F., Imperatori M., Calabro L., Di Giacomo A. M., Petrelli F., Pasquini G., Franchina T., Venditti O., Intagliata S., Galvano A., Fioroni I., Vincenzi B., Tonini G., Santini D.

المساهمون: Pantano F., Russano M., Berruti A., Mansueto G., Migliorino M.R., Adamo V., Aprile G., Gelibter A., Ficorella C., Falcone A., Russo A., Aieta M., Maio M., Martelli O., Barni S., Napolitano A., Roca E., Quadrini S., Iacono D., Calvetti L., Occhipinti M.A., Cortellini A., Vasile E., Passiglia F., Imperatori M., Calabro L., Di Giacomo A.M., Petrelli F., Pasquini G., Franchina T., Venditti O., Intagliata S., Galvano A., Fioroni I., Vincenzi B., Tonini G., Santini D.

مصطلحات موضوعية: Immunotherapy, malignant pleural effusion, Nivolumab, non-Small-Cell Lung Cancer

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32011207; info:eu-repo/semantics/altIdentifier/wos/WOS:000513082900001; volume:20; issue:3; firstpage:319; lastpage:326; numberofpages:8; journal:EXPERT OPINION ON BIOLOGICAL THERAPY; http://hdl.handle.net/10447/407127Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85079466504

الإتاحة: https://doi.org/10.1080/14712598.2020.1724953Test
http://hdl.handle.net/10447/407127Test

المؤلفون: Russo A., Russano M., Franchina T., Migliorino M. R., Aprile G., Mansueto G., Berruti A., Falcone A., Aieta M., Gelibter A., Barni S., Maio M., Martelli O., Pantano F., Iacono D., Calvetti L., Quadrini S., Roca E., Vasile E., Imperatori M., Occhipinti M., Galvano A., Petrelli F., Calabro L., Pasquini G., Intagliata S., Ricciardi G. R. R., Tonini G., Santini D., Adamo V.

المساهمون: Russo A., Russano M., Franchina T., Migliorino M.R., Aprile G., Mansueto G., Berruti A., Falcone A., Aieta M., Gelibter A., Barni S., Maio M., Martelli O., Pantano F., Iacono D., Calvetti L., Quadrini S., Roca E., Vasile E., Imperatori M., Occhipinti M., Galvano A., Petrelli F., Calabro L., Pasquini G., Intagliata S., Ricciardi G.R.R., Tonini G., Santini D., Adamo V.

مصطلحات موضوعية: LDH, Nivolumab, NLR, NSCLC, PD-1, PD-L1, PLR, Prognosis

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32002809; info:eu-repo/semantics/altIdentifier/wos/WOS:000510269600001; volume:37; issue:3; firstpage:1145; lastpage:1155; numberofpages:11; journal:ADVANCES IN THERAPY; http://hdl.handle.net/10447/407357Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85078863228

الإتاحة: https://doi.org/10.1007/s12325-020-01229-wTest
http://hdl.handle.net/10447/407357Test

المؤلفون: Tartarone A, Roviello G, Lerose R, Roudi R, Aieta M, Zoppoli P.

المساهمون: Tartarone, A, Roviello, G, Lerose, R, Roudi, R, Aieta, M, Zoppoli, P.

مصطلحات موضوعية: atezolizumab, avelumab, checkpoint inhibitor, immunotherapy, meta-analysi, nivolumab, non-small-cell lung cancer, pembrolizumab, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, B7-H1 Antigen, Carcinoma, Non-Small-Cell Lung, Human, Lung Neoplasm, Programmed Cell Death 1 Receptor, Progression-Free Survival, Survival Analysis

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000478996300011; volume:15; issue:20; firstpage:2423; lastpage:2433; numberofpages:11; journal:FUTURE ONCOLOGY; https://hdl.handle.net/11588/898547Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85070081200

الإتاحة: https://doi.org/10.2217/fon-2018-0868Test
https://hdl.handle.net/11588/898547Test

المؤلفون: Giuseppina Rosaria Rita Ricciardi, Antonio Galvano, Francesco Pantano, Alain Gelibter, Michele Aieta, Daniele Santini, Marco Russano, Giulia Pasquini, Alessandro Russo, Lorenzo Calvetti, Giovanni Mansueto, Giuseppe Aprile, Giuseppe Tonini, Enrico Vasile, Sandro Barni, Marco Imperatori, Fausto Petrelli, Tindara Franchina, Michele Maio, Elisa Roca, Luana Calabrò, Maria Rita Migliorino, Daniela Iacono, Olga Martelli, Silvia Quadrini, Salvatore Intagliata, Vincenzo Adamo, Mario Occhipinti, Alfredo Falcone, Antonio Russo, Alfredo Berruti

المساهمون: Russo A., Russano M., Franchina T., Migliorino M.R., Aprile G., Mansueto G., Berruti A., Falcone A., Aieta M., Gelibter A., Barni S., Maio M., Martelli O., Pantano F., Iacono D., Calvetti L., Quadrini S., Roca E., Vasile E., Imperatori M., Occhipinti M., Galvano A., Petrelli F., Calabro L., Pasquini G., Intagliata S., Ricciardi G.R.R., Tonini G., Santini D., Adamo V.

مصطلحات موضوعية: Oncology, Male, 030213 general clinical medicine, Lung Neoplasms, Neutrophils, Lymphocyte, non-small cell lung cancer (NSCLC), Disease, NSCLC, chemistry.chemical_compound, Leukocyte Count, 0302 clinical medicine, Antineoplastic Agents, Immunological, Carcinoma, Non-Small-Cell Lung, PD-1, 80 and over, Leukocytes, Pharmacology (medical), Lymphocytes, Non-Small-Cell Lung, Aged, 80 and over, biology, General Medicine, Middle Aged, Prognosis, Immunological, medicine.anatomical_structure, Nivolumab, 030220 oncology & carcinogenesis, LDH, NLR, PD-L1, PLR, Adult, Aged, Biomarkers, Female, Humans, Retrospective Studies, medicine.medical_specialty, Antineoplastic Agents, NO, 03 medical and health sciences, Lactate dehydrogenase, Internal medicine, medicine, Neutrophil to lymphocyte ratio, business.industry, Carcinoma, medicine.disease, Rheumatology, chemistry, biology.protein, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80c230a8687a20374423c1bcc7d7f441Test
http://hdl.handle.net/11392/2492539Test

المؤلفون: Francesco Passiglia, Michele Aieta, Marco Imperatori, Giovanni Mansueto, Marco Russano, Alfredo Berruti, Giulia Pasquini, Daniele Santini, Elisa Roca, Tindara Franchina, Lorenzo Calvetti, Antonio Galvano, Anna Maria Di Giacomo, Iacopo Fioroni, Giuseppe Aprile, Daniela Iacono, Alessio Cortellini, Sandro Barni, Olga Martelli, Luana Calabrò, Michele Maio, Alain Gelibter, Maria Rita Migliorino, Bruno Vincenzi, Alessandro Russo, Corrado Ficorella, Olga Venditti, Silvia Quadrini, Salvatore Intagliata, Enrico Vasile, Giuseppe Tonini, Fausto Petrelli, Vincenzo Adamo, Alfredo Falcone, Mario Occhipinti, Antonio Russo, Andrea Napolitano, Francesco Pantano

المساهمون: Pantano F., Russano M., Berruti A., Mansueto G., Migliorino M.R., Adamo V., Aprile G., Gelibter A., Ficorella C., Falcone A., Russo A., Aieta M., Maio M., Martelli O., Barni S., Napolitano A., Roca E., Quadrini S., Iacono D., Calvetti L., Occhipinti M.A., Cortellini A., Vasile E., Passiglia F., Imperatori M., Calabro L., Di Giacomo A.M., Petrelli F., Pasquini G., Franchina T., Venditti O., Intagliata S., Galvano A., Fioroni I., Vincenzi B., Tonini G., Santini D.

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Clinical Biochemistry, Kaplan-Meier Estimate, Disease-Free Survival, Drug Administration Schedule, NO, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, Drug Discovery, medicine, Malignant pleural effusion, Humans, immunotherapy, malignant pleural effusion, nivolumab, non-small-cell lung cancer, In patient, Lung cancer, Immune Checkpoint Inhibitors, Retrospective Studies, Pharmacology, business.industry, Brain Neoplasms, Liver Neoplasms, Immunotherapy, medicine.disease, Prognosis, Pleural Effusion, Malignant, respiratory tract diseases, 030104 developmental biology, Treatment Outcome, 030220 oncology & carcinogenesis, Female, sense organs, Non small cell, Nivolumab, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78b5be2e8e2810f947ef83391c385b04Test
http://hdl.handle.net/11573/1484803Test